{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-12-16T12:26:24.497441+00:00",
  "news": [
    {
      "title": "How Amgen’s New CD19-Targeted gMG Approval At Amgen (AMGN) Has Changed Its Investment Story - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxONm8yRFRraUlneDZsaDdkVzNrLW16RnYzS1E4VHdHeUxvbzRicDRYMGgxQzdqSWVZeDF6REJzR3lza2thUTA2TjQ2QWQ5NnVIS0lMUEhsMHpIVEExYnJWNlBCTVFvV1plQ19Pb0dnSUVLZFZZZW8xOEMzNWJNbnVKQXZSVjQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxONm8yRFRraUlneDZsaDdkVzNrLW16RnYzS1E4VHdHeUxvbzRicDRYMGgxQzdqSWVZeDF6REJzR3lza2thUTA2TjQ2QWQ5NnVIS0lMUEhsMHpIVEExYnJWNlBCTVFvV1plQ19Pb0dnSUVLZFZZZW8xOEMzNWJNbnVKQXZSVjQ?oc=5\" target=\"_blank\">How Amgen’s New CD19-Targeted gMG Approval At Amgen (AMGN) Has Changed Its Investment Story</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-16T06:05:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Leo Pharma taps Amgen executive as new SVP of Global Product Strategy - medwatch.com",
      "link": "https://news.google.com/rss/articles/CBMib0FVX3lxTE9HX1RRT3dBX29iYmxmQmhOMUlROVhjTlNodEpNMDRMV0diSWpmNXZjY1FXUmgzWHFfWVBMa0NTMHB0M0pIcHRDNUdyeHlkdzBaeUR3NzhzSm0tbnI2a3pZMFFBakcxV2VDN3pXSmpHYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMib0FVX3lxTE9HX1RRT3dBX29iYmxmQmhOMUlROVhjTlNodEpNMDRMV0diSWpmNXZjY1FXUmgzWHFfWVBMa0NTMHB0M0pIcHRDNUdyeHlkdzBaeUR3NzhzSm0tbnI2a3pZMFFBakcxV2VDN3pXSmpHYw?oc=5\" target=\"_blank\">Leo Pharma taps Amgen executive as new SVP of Global Product Strategy</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">medwatch.com</font>",
      "published": "2025-12-16T10:07:00+00:00",
      "source": "medwatch.com"
    },
    {
      "title": "Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 - Amgen",
      "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPOURKbzJfc1BFUkM4VThkel81UFhMWXVwVVczMEVsX2JoeUZLU0Zxbm5acEZQM2Z1ckEtSldKY3luT3I2em5LX0FDcGpSaW9OSVFSVHRIckl4SHl3LWNDa21VcW1EdVZPX3RJZXhmREJUb0lQaFp4QlNIV2NOcXZQazdVSnZyYTlEM1ZLQmlGaW5OZGo4QlhtSE1DcXk1dWs3blkySUZTZGh5RldlcFlqTW1qM1ItSEE1RHc1ZEotQk10dU1QdTQ0NFBJQnYtcEdHUkFZRnBYMzdwTzJFcmFUZWJKMDhZdGpUUHc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPOURKbzJfc1BFUkM4VThkel81UFhMWXVwVVczMEVsX2JoeUZLU0Zxbm5acEZQM2Z1ckEtSldKY3luT3I2em5LX0FDcGpSaW9OSVFSVHRIckl4SHl3LWNDa21VcW1EdVZPX3RJZXhmREJUb0lQaFp4QlNIV2NOcXZQazdVSnZyYTlEM1ZLQmlGaW5OZGo4QlhtSE1DcXk1dWs3blkySUZTZGh5RldlcFlqTW1qM1ItSEE1RHc1ZEotQk10dU1QdTQ0NFBJQnYtcEdHUkFZRnBYMzdwTzJFcmFUZWJKMDhZdGpUUHc?oc=5\" target=\"_blank\">Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-05T08:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPdzdabm5oVWZTbklRTE1GUEdQWFNOTnFQOFdUZF9rU2FwZ1ZaRzJoZDdCS1hYdy1ZQUdUNXhSaUNfYmFjV2RjR3MzaTlRNkZSNU1wOHBYcXhkSmw4VUcxRDgzMktpcjk4YktMWmZUNzFCQXRMazJHMThUX2JMUGVOUnAyMWhJQlNQX19OUURxQ3A0dmVZc2dnN201WHJucnFndTdfZ0pB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxPdzdabm5oVWZTbklRTE1GUEdQWFNOTnFQOFdUZF9rU2FwZ1ZaRzJoZDdCS1hYdy1ZQUdUNXhSaUNfYmFjV2RjR3MzaTlRNkZSNU1wOHBYcXhkSmw4VUcxRDgzMktpcjk4YktMWmZUNzFCQXRMazJHMThUX2JMUGVOUnAyMWhJQlNQX19OUURxQ3A0dmVZc2dnN201WHJucnFndTdfZ0pB?oc=5\" target=\"_blank\">Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-12-12T14:49:19+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "What Amgen (AMGN)'s Expanded UPLIZNA Approval in Generalized Myasthenia Gravis Means For Shareholders - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPRjdxQTVESGJwdHJhZDkwYXoxaVR6VmgxaUdCUXpvMElUS0xicDRqSzdfQm1pRmZmSmlkeHFpWFB1WXJsRlZGTzFHZXRlcTVzS2l4NnNqamwtVksxNkNLbm9oeVVONXdXVzhIaE4xbDQtVm4xNmV6aGt0cWsySUJ5SzV5aE9FS1k2RzhXLWpvRnl2Vm5FYTZRUzRSVGVwN0NMT2dkc2VWZl9femU5ZlZWeDU4UGxjZE52Z09FMlA1QWJuWVBUYk1MZjA4YlU1WEpVQmtwMHJR0gHbAUFVX3lxTE1JelRGa2hnMTZvbWdLQ0dlQkJyQTJyaGZDWlV1ekVHUU42dU4xN05TS0I4VlktRmo2RGNLMENnQ1JyWnVoSnpMWGtsTXY4d2l5RlVRcWRUd0liZ3BEa2xoTG8zb3E3YVhLMldHSlNIcGhjeERpVFVreEthVy1GaExYcU8tc05vS1R4ZmROakFaMi1BWUhNUkt3Q0dELTVwMWpNQ2xXOVlfWFh6SHVkSmhNUW5IUFpaemE3OWV5RWtFbzhyS0lwMHpSaTE5M3hlcWktOTFTcnpLVS1HVQ?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">What Amgen (AMGN)'s Expanded UPLIZNA Approval in Generalized Myasthenia Gravis Means For Shareholders</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-12-16T05:22:22+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Goldman Sachs, Amgen share gains lead Dow's 125-point climb - MSN",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQWmNiczJfRzB5Wmk2T2xsWmxtZHFGbnJEMGhhMTktUVNWc1ZxeXl6dlNDeVlpQ0FRd29BNnV6UVNST2VnQmFjM1lJd0ptZWplYXpHN0Z2U0d1SWdEYWwzSFRHVjM4cHlQdzdXdE1YLW9nOER3VzdQRDlBdzByTGQ0OC1NbC1oUlhxdVVGUF94M21zZEZWOHQyNW5yV2dCbUlCeUYxYmFtMzd1cmtrZFBOc3QyVXlMenFoZzhqSkVjNkUwMlFIbENGUUdhaHFqaDJXOFE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQWmNiczJfRzB5Wmk2T2xsWmxtZHFGbnJEMGhhMTktUVNWc1ZxeXl6dlNDeVlpQ0FRd29BNnV6UVNST2VnQmFjM1lJd0ptZWplYXpHN0Z2U0d1SWdEYWwzSFRHVjM4cHlQdzdXdE1YLW9nOER3VzdQRDlBdzByTGQ0OC1NbC1oUlhxdVVGUF94M21zZEZWOHQyNW5yV2dCbUlCeUYxYmFtMzd1cmtrZFBOc3QyVXlMenFoZzhqSkVjNkUwMlFIbENGUUdhaHFqaDJXOFE?oc=5\" target=\"_blank\">Goldman Sachs, Amgen share gains lead Dow's 125-point climb</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2025-12-15T22:24:22+00:00",
      "source": "MSN"
    },
    {
      "title": "Amgen (AMGN) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025 - ts2.tech",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNb0h4ZERROVVtNWVLcHlCVW9uUDV0V0M1anUtajBwcENJT2lGbEFoMEs5V2FldGxqaXdNSEM1YlRSRUs4Z2g0NEVUWHZDdzlRVVdxV0c1Z1d1ZUQwMEx3dlZveU5keGdqX0d2MXZjV3RhWl9pVW9MTmJKdzNZU3dWV1h5Q29LeGxvX2tWeG1TY2xzc0ZSenJzNQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxNb0h4ZERROVVtNWVLcHlCVW9uUDV0V0M1anUtajBwcENJT2lGbEFoMEs5V2FldGxqaXdNSEM1YlRSRUs4Z2g0NEVUWHZDdzlRVVdxV0c1Z1d1ZUQwMEx3dlZveU5keGdqX0d2MXZjV3RhWl9pVW9MTmJKdzNZU3dWV1h5Q29LeGxvX2tWeG1TY2xzc0ZSenJzNQ?oc=5\" target=\"_blank\">Amgen (AMGN) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">ts2.tech</font>",
      "published": "2025-12-15T00:09:52+00:00",
      "source": "ts2.tech"
    },
    {
      "title": "Amgen Sees RS Rating Improve To 71 - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOUWhrZ3huMDMyd1ZISHVWa1o1TXpTR2lRTlpfbXhSd3k0Ny1VTHgxNXIxYTd0WjhaeGs4dENfb1hkLWZjdTV6UnlXR2FIY1JINzNBTHRBVmk3bndNX1FEZFFlRDRPQzgwMkVidXBJMGVRWmJPQUxEY1dUbnFKUGpmQVpadEk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxOUWhrZ3huMDMyd1ZISHVWa1o1TXpTR2lRTlpfbXhSd3k0Ny1VTHgxNXIxYTd0WjhaeGs4dENfb1hkLWZjdTV6UnlXR2FIY1JINzNBTHRBVmk3bndNX1FEZFFlRDRPQzgwMkVidXBJMGVRWmJPQUxEY1dUbnFKUGpmQVpadEk?oc=5\" target=\"_blank\">Amgen Sees RS Rating Improve To 71</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-12-15T08:00:00+00:00",
      "source": "Investor's Business Daily"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-12-15",
      "close": 325.30999755859375
    },
    "history": [
      {
        "date": "2025-12-05",
        "close": 329.8900146484375
      },
      {
        "date": "2025-12-08",
        "close": 321.2300109863281
      },
      {
        "date": "2025-12-09",
        "close": 313.8500061035156
      },
      {
        "date": "2025-12-10",
        "close": 315.3800048828125
      },
      {
        "date": "2025-12-11",
        "close": 317.3800048828125
      },
      {
        "date": "2025-12-12",
        "close": 317.739990234375
      },
      {
        "date": "2025-12-15",
        "close": 325.30999755859375
      }
    ],
    "name": "Amgen Inc."
  }
}